Morpholino

MO3-igf2b

ID
ZDB-MRPHLNO-100527-1
Name
MO3-igf2b
Previous Names
None
Target
Sequence
5' - AATGATGTTTTAGTTGGTCCTCCAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO3-igf2b
Phenotype
Phenotype resulting from MO3-igf2b
Phenotype Fish Figures
angiogenesis disrupted, abnormal y1Tg + MO3-igf2b text only from Hartnett et al., 2010
apoptotic process increased occurrence, abnormal AB + MO3-igf2b Fig. S4 with image from Hartnett et al., 2010
blood decreased fluid flow, abnormal AB + MO3-igf2b Fig. S6 with image from Hartnett et al., 2010
blood circulation disrupted, abnormal AB + MO3-igf2b Fig. 6 with imageFig. S6 with image from Hartnett et al., 2010
brain structure, abnormal AB + MO3-igf2b Fig. 1 with image from Hartnett et al., 2010
bulbus arteriosus morphology, abnormal AB + MO3-igf2b Fig. 6 with image from Hartnett et al., 2010
dorsal/ventral pattern formation disrupted, abnormal AB + MO3-igf2b Fig. S5 with image from Hartnett et al., 2010
eye decreased size, abnormal AB + MO3-igf2b Fig. 1 with image from Hartnett et al., 2010
heart increased size, abnormal AB + MO3-igf2b Fig. 6 with image from Hartnett et al., 2010
heart contraction decreased occurrence, abnormal AB + MO3-igf2b text only from Hartnett et al., 2010
heart looping arrested, abnormal AB + MO3-igf2b Fig. 6 with image from Hartnett et al., 2010
intermediate cell mass of mesoderm distended, abnormal AB + MO3-igf2b Fig. 1 with image from Hartnett et al., 2010
neural keel apoptotic, abnormal AB + MO3-igf2b Fig. S4 with image from Hartnett et al., 2010
post-vent vasculature increased accumulation blood, abnormal AB + MO3-igf2b Fig. S6 with image from Hartnett et al., 2010
somite morphology, abnormal AB + MO3-igf2b Fig. 1 with image from Hartnett et al., 2010
trunk vasculature increased accumulation blood, abnormal AB + MO3-igf2b Fig. S6 with image from Hartnett et al., 2010
vasculature increased accumulation blood, abnormal AB + MO3-igf2b Fig. S6 with image from Hartnett et al., 2010
whole organism decreased length, abnormal AB + MO3-igf2b Fig. 1 with image from Hartnett et al., 2010
whole organism wholly ventralized, abnormal AB + MO3-igf2b Fig. 1 with imageFig. S5 with image from Hartnett et al., 2010
Phenotype of all Fish created by or utilizing MO3-igf2b
Phenotype Fish Conditions Figures
post-vent vasculature increased accumulation blood, abnormal AB + MO3-igf2b standard conditions Fig. S6 with image from Hartnett et al., 2010
blood decreased fluid flow, abnormal AB + MO3-igf2b standard conditions Fig. S6 with image from Hartnett et al., 2010
brain structure, abnormal AB + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
whole organism wholly ventralized, abnormal AB + MO3-igf2b standard conditions Fig. 1 with imageFig. S5 with image from Hartnett et al., 2010
heart contraction decreased occurrence, abnormal AB + MO3-igf2b standard conditions text only from Hartnett et al., 2010
dorsal/ventral pattern formation disrupted, abnormal AB + MO3-igf2b standard conditions Fig. S5 with image from Hartnett et al., 2010
bulbus arteriosus morphology, abnormal AB + MO3-igf2b standard conditions Fig. 6 with image from Hartnett et al., 2010
trunk vasculature increased accumulation blood, abnormal AB + MO3-igf2b standard conditions Fig. S6 with image from Hartnett et al., 2010
vasculature increased accumulation blood, abnormal AB + MO3-igf2b standard conditions Fig. S6 with image from Hartnett et al., 2010
heart increased size, abnormal AB + MO3-igf2b standard conditions Fig. 6 with image from Hartnett et al., 2010
eye decreased size, abnormal AB + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
somite morphology, abnormal AB + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
blood circulation disrupted, abnormal AB + MO3-igf2b standard conditions Fig. 6 with imageFig. S6 with image from Hartnett et al., 2010
apoptotic process increased occurrence, abnormal AB + MO3-igf2b standard conditions Fig. S4 with image from Hartnett et al., 2010
whole organism decreased length, abnormal AB + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
neural keel apoptotic, abnormal AB + MO3-igf2b standard conditions Fig. S4 with image from Hartnett et al., 2010
heart looping arrested, abnormal AB + MO3-igf2b standard conditions Fig. 6 with image from Hartnett et al., 2010
intermediate cell mass of mesoderm distended, abnormal AB + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
angiogenesis disrupted, abnormal y1Tg + MO3-igf2b standard conditions text only from Hartnett et al., 2010
intersegmental vessel sprouting angiogenesis disrupted, abnormal y7Tg + MO2-igf2b + MO3-igf2b + MO4-tp53 standard conditions Fig. 4 with image from Dallinga et al., 2018
intersegmental vessel filopodium decreased amount, abnormal y7Tg + MO2-igf2b + MO3-igf2b + MO4-tp53 standard conditions Fig. 4 with image from Dallinga et al., 2018
blood circulation disrupted, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 4 with imageFig. 6 with image from Hartnett et al., 2010
blood decreased fluid flow, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 4 with image from Hartnett et al., 2010
dorsal/ventral pattern formation disrupted, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 3 with image from Hartnett et al., 2010
heart looping arrested, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 6 with image from Hartnett et al., 2010
whole organism decreased length, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
brain structure, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
vasculature increased accumulation blood, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 4 with image from Hartnett et al., 2010
intermediate cell mass of mesoderm distended, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
somite morphology, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
post-vent vasculature increased accumulation blood, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 4 with image from Hartnett et al., 2010
apoptotic process increased occurrence, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 2 with image from Hartnett et al., 2010
eye decreased size, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 1 with image from Hartnett et al., 2010
bulbus arteriosus morphology, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 6 with image from Hartnett et al., 2010
trunk vasculature increased accumulation blood, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 4 with image from Hartnett et al., 2010
heart increased size, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 6 with image from Hartnett et al., 2010
heart contraction decreased occurrence, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions text only from Hartnett et al., 2010
whole organism wholly ventralized, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 1 with imageFig. 3 with image from Hartnett et al., 2010
neural keel apoptotic, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 2 with image from Hartnett et al., 2010
spinal cord neural keel apoptotic, abnormal AB + MO1-igf2a + MO3-igf2b standard conditions Fig. 2 with image from Hartnett et al., 2010
cranial blood vessel decreased size, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with image from Hartnett et al., 2010
angiogenesis disrupted, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with imageFig. S7 with imagetext only from Hartnett et al., 2010
parachordal vessel hypoplastic, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with image from Hartnett et al., 2010
intersegmental vessel decreased size, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with image from Hartnett et al., 2010
parachordal vessel morphology, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with image from Hartnett et al., 2010
intermediate cell mass of mesoderm distended, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with image from Hartnett et al., 2010
intersegmental vessel disorganized, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with image from Hartnett et al., 2010
vasculature disorganized, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. S7 with image from Hartnett et al., 2010
ocular blood vessel decreased size, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with image from Hartnett et al., 2010
sprouting angiogenesis decreased occurrence, abnormal y1Tg + MO1-igf2a + MO3-igf2b standard conditions Fig. 5 with image from Hartnett et al., 2010
Citations